COST-BENEFIT-ANALYSIS OF PROSPECTIVE PHARMACOKINETIC DOSING OF NORTRIPTYLINE IN DEPRESSED INPATIENTS

被引:41
作者
SIMMONS, SA
PERRY, PJ
RICKERT, ED
BROWNE, JL
机构
[1] UNIV IOWA,COLL PHARM,IOWA CITY,IA 52242
[2] UNIV IOWA,COLL MED,DEPT PSYCHIAT,IOWA CITY,IA 52242
关键词
D O I
10.1016/0165-0327(85)90071-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:47 / 53
页数:7
相关论文
共 8 条
[1]  
AMDISEN A, 1981, ACTA PSYCHIAT SCAND, V61, P261
[2]   INDIVIDUALIZING GENTAMICIN DOSAGE REGIMENS IN BURN PATIENTS WITH GRAM-NEGATIVE SEPTICEMIA - COST-BENEFIT-ANALYSIS [J].
BOOTMAN, JL ;
WERTHEIMER, AI ;
ZASKE, D ;
ROWLAND, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (03) :267-272
[3]  
BROWNE JL, 1983, J CLIN PSYCHOPHARM, V3, P351
[4]   COST-BENEFIT AND COST-EFFECTIVENESS - METHODOLOGIES FOR EVALUATING INNOVATIVE PHARMACEUTICAL SERVICES [J].
MCGHAN, WF ;
ROWLAND, CR ;
BOOTMAN, JL .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (02) :133-140
[5]  
PESKIN J, 1982, MEASURING HOUSEHOLD, V3, P16
[6]   COST-BENEFIT AND COST-EFFECTIVENESS ANALYSIS IN HEALTH-CARE - GROWTH AND COMPOSITION OF THE LITERATURE [J].
WARNER, KE ;
HUTTON, RC .
MEDICAL CARE, 1980, 18 (11) :1069-1084
[7]  
1981, CURRENT POPULATION R
[8]  
1980, AFFECTIVE DISORDERS